AccessPak for HIV PEP Expanded with Viracept and Lanreotide Subcutaneous
Determining the interaction of AccessPak for HIV PEP Expanded with Viracept and Lanreotide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emtricitabine / nelfinavir / tenofovir
Brand name: AccessPak for HIV PEP Expanded with Viracept
Synonyms: n.a.
Generic Name: lanreotide
Brand name: Somatuline Depot
Synonyms: Lanreotide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- AccessPak for HIV PEP Expanded with Viracept-Lansoprazole
- AccessPak for HIV PEP Expanded with Viracept-Lansoprazole Delayed-Release Capsules
- AccessPak for HIV PEP Expanded with Viracept-Lansoprazole Orally Disintegrating Tablets
- AccessPak for HIV PEP Expanded with Viracept-Lansoprazole, Amoxicillin, and Clarithromycin
- AccessPak for HIV PEP Expanded with Viracept-Lanthanum
- AccessPak for HIV PEP Expanded with Viracept-Lanthanum carbonate
- Lanreotide Subcutaneous-Accolate
- Lanreotide Subcutaneous-Accretropin
- Lanreotide Subcutaneous-Accucaine
- Lanreotide Subcutaneous-AccuHist Drops
- Lanreotide Subcutaneous-AccuHist PDX Drops
- Lanreotide Subcutaneous-AccuHist PDX Syrup